Leukemia/Lymphoma Research
The
Pediatric Oncology Branch treats leukemia and lymphoma patients with multiple
relapses or those that have not responded to standard therapy. For those
children with leukemia or lymphoma for whom effective treatment no longer
exists, the Pediatric Oncology Branch has trials of new, experimental
anti-cancer drugs and one non-myeloablative bone marrow transplantation
protocol.
The Pediatric Oncology Branch has also focused research efforts on the
treatment of meningeal leukemia (leukemia which has spread to the meninges
or covering of the brain and spinal cord). An experimental protocol is
available for children who have relapsed in the meninges.
The Pediatric Oncology Branch has also focused research efforts on the
treatment of meningeal leukemia (leukemia which has spread to the meninges
or covering of the brain and spinal cord). A number of protocols utilizing
anti-leukemia drugs exist for children who have relapsed in meninges.
For children with relapsed ALL for whom effective treatment no longer
exists, the Pediatric Oncology Branch has Phase
1 clinical trials of a spectrum of new, experimental anti-cancer drugs.
Additional information on Phase 1 trials can be obtained from the Pharmacology
and Experimental Therapeutics Section.
Alan Wayne,
MD Leukemia/Lymphoma research
Leukemia Protocols
Last Updated: March
10, 2003
NCI
Home Page|| NIH Home Page
© 2002-2003, Pediatric Oncology Branch, Center for Cancer Research,
National Cancer Institute
|